Barcelona, Spain

Pau Ferrer

This inventor holds 2 USPTO granted patents. Top assignees: Novo Nordisk A/s, Novozymes A/s. Active years: 1999-2001.


% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Esplugues De Llobregat, ES (1999)
  • Barcelona, ES (2001)

Company Filing History:


Years Active: 1999-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pau Ferrer: Innovator in Enzyme Technology

Introduction

Pau Ferrer is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of biotechnology, particularly in enzyme technology. With a total of 2 patents, his work has implications for various applications in the industry.

Latest Patents

Ferrer’s latest patents focus on enzymes with β-1,3-glucanase activity. The first patent describes a DNA construct that exhibits this activity, which includes specific DNA sequences and analogues that are homologous or capable of hybridization. This invention also encompasses an expression vector, cells harboring the DNA constructs, and methods for producing the novel enzyme. The second patent further elaborates on the DNA construct and its applications in degrading or modifying β-glucan containing materials.

Career Highlights

Throughout his career, Pau Ferrer has worked with prominent companies in the biotechnology sector, including Novozymes A/S and Novo Nordisk A/S. His experience in these organizations has allowed him to develop and refine his innovative ideas in enzyme technology.

Collaborations

Ferrer has collaborated with notable professionals in his field, including Lisbeth Hedegaard and Torben Halkier. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Pau Ferrer is a distinguished inventor whose work in enzyme technology has led to valuable patents and collaborations. His contributions continue to influence the biotechnology industry and pave the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…